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ABSTRACT 
Background.  Intraventricular haemorrhage (IVH) and cystic periventricular leukomalacia (cPVL) 
contribute to neonatal mortality and morbidity.  Low birth weight and gestational age are amongst 
the risk factors for IVH and cPVL.  
Objectives.  To assess how many very low birth weight (VLBW) infants had cranial ultrasound 
screening at Charlotte Maxeke Johannesburg Academic Hospital (CMJAH) and to determine the 
prevalence of cranial ultrasound abnormalities.  In addition, to compare the characteristics and risk 
factors of those VLBW infants with cranial ultrasound abnormalities to those with normal cranial 
ultrasound findings.   
Methods.  This was a retrospective case-controlled study of infants < 1 500g admitted to CMJAH 
from 1 January 2013 to 31 December 2015.  Cases were identified as infants with IVH or cPVL.  
Controls were matched 1:2 based on birth weight and gender.  
Results.  Only 55% (856/1562) of VLBW infants had undergone cranial ultrasound screening.  The 
prevalence of IVH was 26% (219/856).  A total of 197 cases were identified and matched with 394 
controls.  Antenatal care was lower in cases (71% vs 79%; P=0.039). Sepsis, ventilation, metabolic 
acidosis and patent ductus arteriosus were all significantly higher in cases.  The use of antenatal 
steroids was significantly higher in the grade I-II IVH/no IVH group vs grade III-IV IVH group 
(44% vs 25%; P=0.017).   
Conclusion.  The prevalence of IVH is consistent with that of developed countries.  Improving 
antenatal care, infection control and adequate early resuscitation could decrease the incidence of IVH 
and cPVL.  All VLBW infants should undergo cranial ultrasound screening. 
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Background 
 
Periventricular-intraventricular haemorrhage (IVH) and white matter injury (WMI), particularly 
cystic periventricular leukomalacia (cPVL), are major contributors to mortality and long-term 
morbidity in preterm infants.[1,2]  The immature blood-brain barrier combined with fluctuation in 
cerebral blood flow, or platelet and coagulation disorders, form the basis for IVH pathogenesis.  Risk 
factors for IVH include low birth weight, gestational age, prematurity, lack of antenatal steroids, 
asphyxia, prolonged labour, respiratory distress syndrome, recurrent tracheal suctioning, hypoxia, 
hypercarbia, acidosis, patent ductus arteriosus (PDA), rapid infusion of sodium bicarbonate and inter 
hospital transfer.[3]  Preterm infants with cystic PVL without IVH appear to have a different risk 
pattern, although the pathogenesis does involve both hypoxic-ischaemic and haemorrhagic 
processes.  It also appears that intrauterine inflammation and cytokine release result in oxidative 
stress to white matter.[4,5]  
 
IVH can be graded according to severity from grade I-IV, with the most commonly used 
classification being that of Papile et al.[6]  The incidence of IVH in developed countries is about 20-
25% of all very low birth weight (VLBW) infants.  More than 50% of those with severe IVH develop 
intellectual disability or cerebral palsy.[7]  Research done in Southern Africa, however, showed a 
higher incidence of between 20-50% of IVH in VLBW infants although the prevalence of severe 
IVH is similar to that of developed countries.[8-10] 
 
Most neonatal units have a screening protocol in place to detect IVH or cPVL. The American 
Academy of Neurology suggests cranial ultrasound screening be performed at two time points for all 
infants with a gestational age less than 30 weeks:  between week 1 and 2 of life and at 36 to 40 
weeks post menstrual age.[7]  More recent studies have evidence that Magnetic Resonance Imaging 
(MRI) done at term equivalent age could be helpful at identifying white matter abnormalities that 
could cause neurocognitive delay as a long-term outcome.[11]  Cranial ultrasound, however, is still 
the first tool for assessing neurological injury in preterm infants as it allows for bedside investigation 
and sequential evaluation of evolving lesions. 
 
As neonatal and obstetric care improves there is an increase in the survival of preterm infants and 
with this there is a newer burden of disease in the form of neurodevelopmental impairment.[2,12]  In 
order to improve the screening and management of IVH at Charlotte Maxeke Johannesburg 
Academic Hospital (CMJAH) we first need to investigate the prevalence of IVH and cPVL and 
identify the specific risk factors important in our population.  Low birth weight and gestational age 
are risk factors for IVH and therefore we chose to conduct a study that controlled for these possible 
confounders.[13]  
 
Our aim was to assess how many VLBW infants had cranial ultrasound screening and determine the 
prevalence of cranial ultrasound abnormalities in our VLBW population.  We also wanted to 
compare the characteristics, risk factors and short-term outcomes of those VLBW infants with 
cranial ultrasound abnormalities with VLBW infants with normal cranial ultrasound.   
 
Methods 
 
The study design was a retrospective case-controlled study using data from the CMJAH neonatal 
database.  The study population included all VLBW infants admitted to the neonatal unit, including 
the intensive care unit, from 1 January 2013 to 31 December 2015.  CMJAH is a tertiary hospital 
located in Johannesburg, South Africa.  It acts as a referral centre for surrounding clinics and district 
hospitals.  The study population included both inborn and outborn infants.  Infants born with a birth 
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weight less than or equal to 1 500g qualify as very low birth weight.  All VLBW infants who had the 
following ultrasound abnormalities were identified as cases:  IVH, post-haemorrhagic 
hydrocephalous or cPVL.  Cases were matched with control infants based on birth weight category 
and gender on a 1:2 basis.  The two most suitable controls born closest to the study patient were 
selected.  The grading of IVH was done according to the classification described by Papile et al.[6]  
Grade I includes bleeds restricted to the germinal matrix, grade II bleeds extend into the ventricles 
filling less than 50% of the ventricle, grade III bleeding causes ventricular dilatation, and grade IV 
includes parenchymal haemorrhage.  Grade III and IV bleeds constitute severe IVH.  There were 
four birth weight categories:  less than or equal to 750g; 751 – 1 000g; 1 001 -1 250g and 1 251 – 1 
500g.  Infants with major congenital abnormalities of any organ system were excluded.  Infants with 
cranial ultrasound revealing abnormalities such as absent corpus callosum, schizencephaly or 
findings with questionable significance such as periventricular echodensities were also excluded.   
 
Data collection 
Data was collected from the neonatal database REDCap (Research Electronic Data Capture) at 
CMJAH.[14]  It is a secure web-based application that is linked to the Vermont Oxford Network 
(VON).[15]  The VON includes about 1 000 centres around the world that submit data about high-risk 
newborn infants.  It is a non-profit voluntary collaboration of health professionals aiming to improve 
neonatal care.  Its members include both public and private units from North America, Brazil, 
Canada, Europe, the Middle East, Asia and Southern Africa, to name a few.  Sixty-four units in 
South Africa are members of the VON.   
 
The following maternal variables were extracted from the database for each infant:  antenatal care, 
antenatal steroids, magnesium sulphate, chorioamnionitis, HIV, attempted termination of pregnancy, 
hypertension, diabetes and mode of delivery.  Newborn variables were:  place of birth (inborn, 
midwife obstetric unit (MOU), another hospital or home), gestational age, birth weight, head 
circumference, gender, multiple gestation, Apgar at 5 minutes, birth resuscitation, temperature on 
admission and metabolic acidosis.  Birth resuscitation included oxygen, bag mask ventilation, 
intubation, cardiopulmonary resuscitation and/or intravenous adrenaline.  Ultrasound findings were 
also recorded, particularly grade of IVH or presence of cPVL.  The neonatal course was documented 
including respiratory diagnosis, respiratory support, days on continuous positive airways pressure 
(CPAP), days mechanically ventilated, surfactant therapy, supplementary oxygen on day 28, 
indomethacin or ibuprofen exposure and bacterial sepsis (early or late).  Early sepsis constituted a 
positive blood culture within 72 hours of birth and late sepsis was a positive blood culture > 72 hours 
after birth.  Other neonatal diagnoses noted were pneumothorax, patent ductus arteriosus (PDA), 
necrotizing enterocolitis (NEC), neonatal jaundice, blood transfusion, HIV testing and major birth 
defects.  Short term outcome namely survival to discharge was recorded.  Well infants transferred to 
other hospitals were considered survivors. 
 
 
Statistical methods 
Statistical analysis was done using SPSS Statistics (IBM) version 23.  Data was described using 
standard statistical methods.  Continuous data with a normal distribution was described using mean 
and standard deviation, while skewed data was described using median and range.  Categorical 
variables were described using frequencies and percentages.  Univariate analysis was performed to 
describe differences between the case and control groups using the Pearson chi-squared or Fisher’s 
exact test for categorical variables.  Continuous variables were compared using independent t-tests or 
non-parametric tests (Mann Whitney) as appropriate, depending on data distribution.  Basic 
demographic data of the group who had not undergone cranial ultrasound was compared to the final 
study sample that had undergone ultrasound to see if the sample selected was random.  Sub-analysis 
 4 
also included comparison between those with mild/no IVH to severe IVH and cPVL respectively.  A 
p-value ≤ 0.05 was considered significant.  The variables on univariate analysis with a p-value < 0.1 
were analysed further in a stepwise logistic regression model to determine risk factors for IVH and 
cPVL.  
 
 
Ethics 
The Human Research Ethics Committee at the University of the Witwatersrand, Johannesburg, 
approved the study (Clearance certificate No. M151195). 
  
Results 
 
There were 1562 VLBW infants born between 1 January 2013 and 31 December 2015 at CMJAH 
(accessed 01 February 2016).  Cranial ultrasounds were performed on 856 (55%) infants.  The 
prevalence of cranial ultrasound abnormalities at CMJAH is shown in Table 1.  Of the 856 patients 
with cranial ultrasounds, 13 were excluded from the study due to major birth defects.  The remaining 
infants who underwent cranial ultrasound were then divided into normal  (580) and abnormal (263) 
cranial ultrasound groups.  Forty infants in the “abnormal” group (40/263, 15%) were excluded due 
to sonar findings that did not meet inclusion criteria. A further 26 infants with abnormal cranial 
ultrasounds had no matching control with the correct weight category or gender and were thus 
excluded.  There were 186/580 (32%) in the “normal” group who could not be matched with an 
“abnormal” infant.  There were thus 197 cases and 394 controls selected from the infants who had 
undergone cranial ultrasound (see Figure 1). 
 
 
Table 1.  Prevalence of ultrasound abnormalities in VLBW infants 
at CMJAH n (%) 
 CMJAH 
Cranial ultrasounds done 856 (54,8%) 
Normal cranial ultrasound 580 (67,7%) 
Grade I 63 (7,4%) 
Grade II 91 (10,6%) 
Grade III 34 (4%) 
Grade IV 27 (3,2%) 
Cystic PVL 8 (1%) 
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Basic demographic data showed that 47% (729/1562) of infants admitted were males, median birth 
weight was 1150g and mean gestational age was 29 weeks.  The mortality of the overall group was 
27% (415/1562).  There were less males in the group who had not undergone ultrasound (417/702; 
45%) compared to the case/control group (303/591; 51%; P=0.029).  The median weight was higher 
in the group with no ultrasound (1180g vs 1090g in the case/control group; P=0.05).  The mean 
gestational age of 29 weeks was the same for both groups.  Mortality in the group who had not 
undergone ultrasound was higher (279/706; 39% vs 99/591; 17%).  This result had a significant p-
value of 0.026.  This higher mortality could be accounted for by the large amount of infants who 
were ≤750g in the group who had not undergone ultrasound (92/706; 13% vs 18/591; 3%). When 
comparing cases and controls we found that the gender distribution was the same with males 
constituting 49% in both groups.  The mean birth weight for cases was 1097g and 1065g for controls.  
 
VLBW infants in database 
N=1562 
Infants who had cranial 
ultrasound 
N=856 
No cranial ultrasound 
N=706 
No major birth defects 
N=843 
Birth defects 
N=13 
Normal cranial ultrasound 
N=580 
Abnormal cranial 
ultrasound 
N=263 
Controls 
without 
suitable cases 
N=186 
Matched 
controls 
N=394 
Inclusion 
criteria met 
N=223 
Inclusion 
criteria not 
met 
N=40 
Cases 
matched 
N=197 
Cases not 
matched 
N=26 
Controls Final 
Sample 
N=394 
Cases Final Sample 
N=197 
 
Figure 1.  Flow diagram describing sample selection 
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The mean gestational age was 29 weeks for both groups.  The above parameters had no statistical 
significance, which confirms that cases and controls were matched. 
 
The univariate comparison between case and control groups is shown in Table 2.  A higher 
proportion of cases were outborn.  Sepsis, metabolic acidosis, ventilation and PDA were all 
significantly higher in cases.  Antenatal care and Apgar at 5 minutes were lower in cases.  However, 
there was no significant difference between the two groups when it came to antenatal steroids.   
 
The logistic regression analysis included location of birth, antenatal care, maternal hypertension, 
maternal HIV, mode of delivery, Apgar at 5 minutes, initial resuscitation with oxygen, early and late 
bacterial sepsis, PDA and ventilation.  The results are shown in Table 3.  The analysis showed that 
antenatal care (odds ratio [OR]:  0.59; 95% confidence interval [CI]: 0.37–0.95) and Apgar greater 
than 7 at 5 minutes (OR:  0.53; 95% CI:  0.34–0.84) were associated with a lower risk of abnormal 
cranial ultrasound.  Ventilation carried a higher risk of cranial ultrasound abnormality (OR:  2.44; 
95% CI:  1.62–3.69) and early bacterial sepsis followed this trend (OR:  3.32; 95% CI:  1.3–8.34).    
 
The rest of the variables were not significantly different between the groups. 
 
 
 
Table 2.  Overall characteristics of cases and controls  
  
 
 Characteristic 
Controls 
(N=394) 
Cases 
(N=197) 
P-value 
Outborn, n (%) 60/392 (15) 45/196 (23) 0.03 
Mortality, n (%) 53/393 (14) 46/197 (23) 0.004 
Maternal factors 
  
  
Antenatal care, n (%) 307/390 (79) 137/194 (71) 0.039 
Antenatal steroids, n (%) 174/386 (45) 73/191 (38) 0.14 
Maternal HIV, n (%) 111/392 (28) 72/197 (37) 0.059 
Hypertension, n (%) 105/386 (27) 37/197 (19) 0.041 
Mode of delivery, n (%)  
  
0.054 
Vaginal 139/385 (36) 83/185 (45)   
Caesarean 246/385 (64) 102/185 (55)   
Neonatal Factors 
Apgar at 5 min n (%) 
  
  
 
 
0.002 
Less than 7 65/360 (18) 52/173 (30)   
7 or greater 295/360 (82) 121/173 (70)   
Resuscitation at birth with oxygen, n (%) 324/394 (82) 148/197 (75) 0.037 
Early bacterial sepsis, n (%) 10/392 (3) 13/197 (7) 0.023 
Late bacterial sepsis, n (%) 156/394 (40) 99/197 (50) 0.02 
Metabolic acidosis, n (%)  18/394 (5) 22/197 (11) 0.005 
Mechanical ventilation, n (%) 102/380 (27) 95/197 (48) <0.001 
PDA, n (%) 57/393 (15) 45/192 (23) 0.015 
Maximum Bilirubin level, mean (± SD) 167 (± 44) 179 (± 55) 0.036 
*Valid cases reported for each variable (i.e. missing information was excluded) 
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Table 3.  Parameters influencing the development of IVH, Severe IVH and cystic PVL, 
identified by logistic regression analysis 
Parameter OR 95% CI P-value 
All cases     
Antenatal care 0.59 0.37 - 0.95 0.03 
Apgar ≥ 7 at 5 minutes 0.53 0.34 - 0.84 0.006 
Early bacterial sepsis 3.32 1.32 - 8.34 0.011 
Mechanical ventilation 
 
2.44 1.62 - 3.69 <0.001 
Severe IVH     
Outborn 3.0 1.22 - 7.41 0.017 
Apgar ≥ 7 at 5 minutes 0.21 0.10 - 0.43 <0.001 
Mechanical ventilation 
 
3.64 1.73 - 7.62 0.001 
Cystic PVL     
Sex (male) 0.11 0.01 - 1.22 0.072 
Chorioamnionitis 45.73 6.27 - 333.68 <0.001 
Mechanical ventilation 15.92 1.54 - 164.36 0.02 
*Valid cases reported for each variable (i.e. missing information was excluded) 
 
 
 
Sub-analyses 
 
Severe IVH within the selected cases, was compared to mild/no IVH from within the case and 
control groups.  Significant results are shown in Table 4.  The use of antenatal steroids in the mild/no 
IVH group is higher (232/527; 44% vs 11/44; 25%: P=0.017).  Logistic regression analysis revealed 
that both outborn and ventilated VLBW infants had a higher risk of severe IVH.  An Apgar score of 
7 or greater had indicated a lower risk of severe IVH.  The results are shown in Table 3. 
 
The sample of infants with cystic PVL was compared to those with mild/no IVH and results are 
detailed in table 5.  The significant factors associated with cystic PVL on univariate analysis were 
sex (female), chorioamnionitis, blood transfusion, late bacterial sepsis as well as ventilation.  
Logistic regression analysis (Table 3) revealed that chorioamnionitis (OR:  45.73; 95% CI:  6.27–
333.68) and ventilation (OR:  15.92; 95% CI:  1.54–164.36) hold a high risk of cystic PVL.   
 
 
 
 
 
 8 
Table 4.  Severe IVH compared to mild IVH/no IVH 
Characteristic 
Mild IVH/No 
abnormality 
Severe IVH 
P-value 
(N=536) (N=47) 
Outborn, n (%) 81/534 (15) 17/47 (36) 0.001 
Mortality, n (%) 78/535 (15) 17/47 (36) <0.001 
Maternal factors 
  
  
Antenatal care, n (%) 410/531 (77) 28/46 (61) 0.019 
Antenatal steroids, n (%) 232/527 (44) 11/44 (25) 0.017 
Neonatal factors 
Apgar at 5 min, n (%) 
  
  
 
 
<0.001 
Less than 7 91/485 (19) 24/41 (59)   
7 or greater 394/485 (81) 17/41 (41)   
Early bacterial sepsis, n (%) 18/535 (3) 5/47 (11) 0.031 
Oxygen on day 28, n (%) 205/517 (40) 23/41 (56) 0.047 
Metabolic acidosis, n (%) 31/536 (6) 7/47 (15) 0.026 
Mechanical ventilation, n (%) 161/519 (31) 29/46 (63) <0.001 
*Valid cases reported for each variable (i.e. missing information was excluded) 
 
 
 
Table 5.  Cystic PVL compared to mild IVH/no IVH 
Characteristic 
Mild IVH/No 
abnormality 
Cystic PVL 
P-value 
(N=536) (N=8) 
Sex (male), n (%) 275/536 (51) 1/8 (13) 0.035 
Mortality, n (%) 78/535 (15) 4/8 (50) 0.001 
Chorioamnionitis, n (%) 18/525 (3) 3/6 (50) 0.001 
Blood transfusion, n (%) 308/532 (58) 8/8 (100) 0.024 
Late bacterial sepsis, n (%) 224/536 (42) 7/8 (88) 0.012 
Mechanical ventilation, n (%) 161/518 (31) 7/8 (88) 0.002 
*Valid cases reported for each variable (i.e. missing information was excluded) 
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Discussion 
 
The main objectives of this study were to look at the prevalence of cranial ultrasound abnormalities 
and associated risk factors.  According to the screening protocol at CMJAH every VLBW should 
have an ultrasound within the first 7 days of life, at 10-14 days of life and one before discharge.[16]  
Only 55% of VLBW infants admitted in the study period had cranial ultrasounds, as compared to the 
VON where more than 90% of VLBW infants had cranial sonars.[15]  Reasons for the low coverage 
rate in our unit include staff shortages at times but more importantly the lack of appropriate 
equipment to perform ultrasound.  The unit only has one sonar machine that is often not functional. 
 
It was shown that patients who did not undergo cranial ultrasound appeared to have a higher 
mortality rate than those who had undergone an ultrasound.  This is partly explained by the fact that 
92/706 (13%) of infants in that group were ≤ 750g.  These infants already make up a high-risk group 
related to the extreme prematurity and are likely to have demised before an ultrasound could be 
performed.  Well VLBW infants admitted with higher birth weights are often sent to the kangaroo 
mother care (KMC) ward and discharged quickly without undergoing cranial ultrasound screening. 
 
The prevalence of IVH (26%) appears to be consistent with that of studies done in developed 
countries and is similar to that reported in the VON over the same time period.[7]  With improvement 
of perinatal care the prevalence appears to have decreased compared to a study done at our sister unit 
Baragwanath Hospital in Soweto 20 years ago, which showed a prevalence of 52% in VLBW 
infants.[8]  The prevalence of severe IVH in this study (7%) is also less than reported in the VON and 
studies from both developed and developing countries.[7-9]   
 
This study confirms what is already known, that infants with IVH have higher mortality and that lack 
of antenatal care, birth asphyxia and sepsis appear to be associated with development of IVH.  
Mechanical ventilation and PDA also had an increased association with IVH and this can be 
explained by fluctuations in cerebral blood flow.[3]  Inborn patients tended to have less IVH than 
those outborn and there are many factors that could explain the higher risk including delay in 
transfer, inadequate monitoring or lack of appropriate management at referral centres.  Contrary to 
other studies, which show a decrease in IVH with antenatal steroids, our study did not show a 
significant difference between the use of antenatal steroids in the case and control groups.[3]  This 
may be due to the fact that the administration of antenatal steroids in our setting is lower than other 
settings.  Only 28% (431/1562) of mothers of VLBW infants had received steroids as compared to 
83.5% coverage in the VON during the same period.  The reason is possibly due to late presentation 
of unbooked mothers.[17]  However, the sub-analysis showed that those with severe IVH had less 
exposure to antenatal steroids than the mild/no IVH group. 
 
Maternal hypertension was also associated with a lower incidence of overall IVH and this is 
consistent with other studies.[13]  In terms of the logistic regression analysis for all IVH cases, the 
major protective factors were antenatal care and Apgar ≥ 7 at 5 minutes.  Sepsis and mechanical 
ventilation showed about a 3-fold increase in IVH and both of those factors can be modified by 
preventative measures.  Severe IVH had similar association on logistic regression analysis to overall 
IVH, but infants that were outborn were shown to have a 3-fold risk of severe IVH and this could be 
prevented by transport of mothers in premature labour to centres with appropriate neonatal services 
before delivery. 
 
In this study the prevalence of cystic PVL was only 1% although mortality was highest in this group 
which is consistent with previous studies.[2]  As explained earlier MRI is a better tool to assess WMI, 
but in our setting this is not feasible due to lack of adequate MRI facilities to service the neonatal 
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unit.  Studies seeking to describe a difference between cystic PVL and IVH have shown that the two 
are not mutually exclusive and there is a possible causal relationship between the two even though 
cystic PVL can be seen as a single pathology in some cases.[4,5]  In this study the sub-analysis 
showed that the female gender, chorioamnionitis and blood transfusion had significant association 
with cystic PVL as well as sepsis and mechanical ventilation, which were both risk factors for IVH 
as well.  However, on multivariate logistic regression analysis the gender association was shown to 
have an insignificant 95% CI and only chorioamnionitis and mechanical ventilation appeared 
significant, although confidence intervals were wide owing to the small sample.  
 
Limitations  
 
The retrospective study design was a limitation.  The disadvantages include information bias and 
difficulty in establishing the temporal relationship between certain variables.  Records that were 
incomplete or missing affect the dataset.  Another limitation is the lack of resources, including both 
staff and equipment, which resulted in deviation from the ultrasound screening protocol and resulted 
in 45% of VLBW infants not being screened.  WMI may be largely underestimated by cranial 
ultrasound alone.  In our setting the access to MRI is inadequate. 
 
Conclusion 
 
This retrospective matched case-control study showed that the prevalence of IVH is consistent with 
that of developed countries and it is encouraging to note that severe IVH is lower in our unit.  It 
confirmed the risk factors for IVH and cystic PVL at CMJAH are in keeping with that found 
globally.  The increased mortality and morbidity in infants with IVH would suggest that we try to 
modify the risk factors found to be significant in our population.  Access and awareness of early 
antenatal care is an important factor in preventing poor perinatal outcome.  Neonatal resuscitation 
training in clinics and hospitals should be given priority as well as correct protocols for transfer of 
infants as well as possible early transfer of mothers in preterm labour to appropriate centres.  
Infection control and methods to decrease the need for mechanical ventilation are important 
interventions that could decrease the incidence of IVH.  In terms of ultrasound screening, early 
detection of lesions gives infants a chance of early intervention services.  Therefore, efforts should 
be made to ensure that all VLBW infants undergo ultrasound screening.  Furthermore, early 
identification of patients with poor prognostic factors could assist with decision-making regarding 
the maximum level of care offered and allocation of resources in an equitable manner.   
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CORRECTIONS TO PROTOCOL 
 
Page 7:  Paragraph 1, Line 10, ‘ten’ changed to ‘twenty’ 
 
Page 9:  Paragraph 2, Line 2, the following was added; ‘’ For every case with IVH that is found, the 
next two babies born within the same weight category and gender, which have normal ultrasounds, 
will be taken as controls. ‘’ 
 
Page 10:  Paragraph 2, Line 4, the following was added; ’’Maternal diabetes and hypertension will 
also be included.’’ 
 
Page 11:  Paragraph 2, Line 7, the following was added; ’’Risk factors will be stratified to severity 
of IVH.  The group of infants without cranial ultrasound will also be analyzed and compared with 
those who had ultrasounds.’’ 
 
Page 13:  Paragraph 1, Line 4, the following was added; ’’Lastly, only the worst grade of IVH is 
recorded on the data sheet thus we will be unable to comment on risk factors associated with 
progression from a lower grade to a higher grade.  The day the ultrasound is done is also not noted so 
temporality of the insult and IVH cannot be determined.’’ 
 
Page 16:  Appendix A, ‘Date of birth’ was removed. 
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GLOSSARY OF TERMS 
CMJAH        Charlotte Maxeke Johannesburg Academic Hospital 
VLBW           Very low birth weight 
IVH               Intraventricular haemorrhage 
WMI             White matter injury 
cPVL             Cystic periventricular leukomalacia 
PVHI             Periventricular haemorrhagic infarction 
MRI               Magnetic Resonance Imaging 
NICU             Neonatal Intensive Care Unit 
REDCap        Research Electronic Data Capture 
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INTRODUCTION 
 
Periventricular-intraventricular haemorrhage (IVH) and white matter injury (WMI), particularly 
cystic periventricular leukomalacia (cPVL), are major contributors to mortality and long-term 
morbidity in preterm infants.  Preterm infants are at high risk for intraventricular haemorrhage.  
Intraventricular haemorrhage in the preterm infant generally has its onset in the ganglionic eminence 
also known as the germinal matrix (1).  This area consists of neuronal and glial precursor cells.  The 
vasculature in the sub ependymal germinal matrix is very dense and fragile owing to paucity of 
pericyctes, reduced fibronectin in the basal lamina and reduced glial fibrillary acidic protein 
expression in the astrocyte end feet.  This immature blood-brain barrier combined with fluctuation in 
cerebral blood flow, or platelet and coagulation disorders, form the basis of IVH pathogenesis (2).  
Risk factors for IVH include prematurity, lack of antenatal steroids, asphyxia, prolonged labour, 
respiratory distress syndrome, recurrent tracheal suctioning, hypoxia, hypercarbia, acidosis, patent 
ductus arteriosus, rapid infusion of sodium bicarbonate and inter hospital transfer. 
 
WMI occurs in a characteristic distribution with the cystic type comprising of focal necrosis in the 
periventricular white matter involving the loss of cellular elements.  There is subsequent cyst 
formation that can be visualised on cranial ultrasound.  Non-cystic WMI is a more diffuse process 
with paucity of oligodendrocytes.  This type is not easily detected on cranial ultrasound and is better 
defined by Magnetic resonance imaging (MRI).  Preterm infants with cystic PVL without evidence 
of IVH appear to have a different risk pattern, although the pathogenesis does involve both hypoxic-
ischaemic and haemorrhagic processes (3,4).  It also appears that intrauterine inflammation and 
cytokine release result in oxidative stress to pre-oligodendrocytes.  However, studies seeking to 
describe a difference between WMI and IVH have shown that the two are not necessarily mutually 
exclusive and there is a possible causal relationship between the two even though cystic PVL can be 
seen as a single pathology in some cases (4,5).  
 
The most commonly used classification for IVH is that of PapIle et al (6).  This classification grades 
IVH according to severity from I-IV; grade I includes bleeds restricted to the germinal matrix, grade 
II the bleed extends into the ventricles filling less than 50% of the ventricle, grade III bleeding 
causes ventricular dilatation, and grade IV includes parenchymal haemorrhage.  Many studies prefer 
to describe a grade IV as periventricular haemorrhagic infarction (PVHI) (1).  In terms of WMI, it is 
often divided into cystic and diffuse PVL with the former being more easily detected on cranial 
ultrasound. 
 
The incidence of IVH in developed countries is about 20-25% of all very low birth weight infants 
(VLBW) and more than 50% of those with severe IVH develop intellectual disability or cerebral 
palsy (7).  Research done in Southern Africa, however, shows a higher incidence of between 20-50% 
of IVH in VLBW although the prevalence of severe IVH is similar  to that of developing countries 
(8–10).  The risk of poor neurological outcome increases with increasing grade of IVH.  Cystic PVL, 
which may be a separate entity or a complication of IVH, is shown to result in cerebral palsy in up to 
90% of cases (11). 
 
Most neonatal units have a screening protocol in place to detect IVH or cPVL. The American 
Academy of Neurology suggests cranial ultrasound screening be performed at two time points for all 
infants with a gestational age less than 30 weeks:  between week 1 and 2 of life and at 36 to 40 
weeks post menstrual age (7).  More recent studies have evidence that MRI done at term equivalent 
age could be helpful at identifying white matter abnormalities that could cause neurocognitive delay 
as a long term outcome (3,7).  Cranial ultrasound, however, is still the first tool for assessing 
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neurological injury in preterm infants as it allows for beside investigation and sequential evaluation 
of evolving lesions.   
 
It is clear that preventative measures aimed at improving neurological outcome are necessary.  Early 
detection of lesions gives infants a chance of early intervention services.  Furthermore, early 
identification of patients with poor prognostic factors could assist with decision-making regarding 
the maximum level of care offered and allocation of resources in an equitable manner (12).  Early 
screening will also allow for appropriate counseling of parents about possible neurological 
impairment.   
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JUSTIFICATION OF THE STUDY 
As neonatal and obstetric care improves we see an increase in survival of preterm infants (11) .  With 
improved survival the morbidity rates increase and we begin to see a newer burden of disease in the 
form of cerebral palsy, cognitive and behavioural problems as well as neurosensory impairment (13).  
In order to improve the screening and management of IVH at Charlotte Maxeke Hospital (CMJAH) 
we first need to investigate the prevalence of IVH and cPVL and identify the specific risk factors 
important in our population.  Once modifiable risk factors are identified we can address areas of 
concern and quantify the short-term sequelae.  A previous study at Baragwanath Hospital published 
in 1994 showed relatively high prevalence of IVH and it would be informative to compare the 
findings at a sister unit twenty years later. 
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AIMS AND OBJECTIVES 
 
AIM 
The aim of this study is to evaluate the prevalence and risk factors of IVH and cPVL in VLBW 
infants at CMJAH.   
 
OBJECTIVES 
1. To determine how many VLBW infants had cranial ultrasound screening and how many 
ultrasounds were abnormal. 
2. To compare the characteristics, risk factors and short-term outcome of those VLBW infants 
with cranial ultrasound abnormalities with VLBW infants with normal cranial ultrasound. 
 
METHOD 
STUDY DESIGN 
A retrospective case-control study using data from the CMJAH neonatal database linked to the 
Vermont Oxford Network.  
 
STUDY POPULATION 
All VLBW infants admitted to the neonatal or NICU at CMJAH for the period of January 2013 to 
October 2015. 
 
INCLUSION CRITERIA 
Cases:  All VLBW babies who had a cranial ultrasound with abnormal findings. 
Controls:  All VLBW babies who had normal cranial ultrasounds.  Cases will be matched 1:2 on a 
birth weight and gender basis.  For every case with IVH that is found, the next two babies born 
within the same weight category and gender, which have normal ultrasounds, will be taken as 
controls.  
 
EXCLUSION CRITERIA 
All babies without any information will be excluded as well as babies with major congenital 
abnormalities of any organ system. 
 
DATA COLLECTION AND ANALYSIS 
 
DATA COLLECTION 
Data will be collected from the neonatal database REDCap (Research Electronic Data Capture) at 
CMJAH.  It is a secure web-based application that is linked to the Vermont Oxford Network and 
uses it’s coding.  The data collected for this database is rigorously checked and verified before 
entered electronically.  A data sheet representing data that is valid to this study will be attached 
(appendix A).  The researcher will capture data using this sheet and all identifying data will be 
removed.  Study numbers will be allocated to each data sheet.  Data will be entered into 
STATISTICA for analysis.  
 
The screening protocol for VLBW infants at CMJAH includes a cranial ultrasound to be done within 
the first 7 days of life, at 10-14 days of life and one before discharge (14).  A paediatric neurologist 
or a neonatologist in the unit does the ultrasounds. 
 
SAMPLE SIZE 
The sample size was calculated using the number of patients with IVH that had antenatal steroids (a 
risk factor for IVH) and the number without IVH that had antenatal steroids in a similar case control 
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study done in 2003 (15).  Considering a matched case control method with 1:2 ratio (case to control), 
p value of 0.05, β of 0.8, an assumed odds ratio of 4 and exposure to antenatal steroids in the control 
group of 70%, 57 subjects and 114 controls will be required. 
 
DATA VARIABLES 
The following maternal and neonatal characteristics will be looked at: 
Maternal – Antenatal care, antenatal steroids, magnesium sulphate, chorioamnionitis, HIV, 
attempted termination of pregnancy and the mode of delivery.  Maternal diabetes and hypertension 
will also be included. 
Neonatal: 
- Place of birth and gestational age 
- Birth weight and head circumference 
- Gender, multiple gestation and Apgar at 5 minutes 
- Initial resuscitation and temperature 
- Cranial ultrasound, grade of IVH, cystic PVL 
- Metabolic acidosis and bacterial sepsis (early and late) 
- Respiratory diagnosis, respiratory support, days on continuous positive airways pressure, 
days ventilated, surfactant therapy, day 28 on oxygen 
- Indomethacin or Brufen exposure 
- Pneumothorax, patent ductus arteriosus, necrotising enterocolitis or neonatal jaundice 
- Blood transfusion, HIV testing 
- Major birth defects 
- Outcome 
 
 
DATA ANALYSIS 
Data will be described using standard statistical methods.  Continuous variables will be described 
using mean and standard deviation where data is distributed normally and median and interquartile 
range will be used for non-parametric data.  Categorical variables will be expressed as frequency or 
percentages.  Comparison between case and controls will be done using unpaired t-test or Mann 
Whitney U-test.  Categorical variables will be compared using Chi-squared analysis.  A p-value of 
less than 0.05 will be considered significant.  Risk factors will be stratified to severity of IVH.  The 
group of infants without cranial ultrasound will also be analysed and compared with those who had 
ultrasounds. 
 
ETHICS  
This protocol will be submitted to the ethics committee of the University of Witwatersrand for 
research on human subjects.  The Neonatal Database REDCap is confidential and has limited 
accessibility.  There will be no identifying information for the patients in the dataset used and study 
numbers will be allocated to create anonymity.  This will ensure confidentiality.  There will no 
interaction with patients directly as this is a retrospective record review, thus there is no risk for 
patient exploitation.  Consent for the study will be obtained from the Chief Executive Officer of 
CMJAH.  Informed consent from the participants is not necessary as this is a retrospective review of 
records.   
Approval from Human Research Committee is pending.   
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TIMING 
 Oct  Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sept 
Literature 
review 
            
Preparing 
protocol 
            
Protocol 
assessment 
            
Ethics 
application 
            
Collecting 
data 
            
Data 
analysis 
            
Writing 
up-Thesis 
            
 
FUNDING 
The only financial considerations are printing and data usage estimated to be about R1000, the 
researcher would cover this expense. 
 
LIMITATIONS 
The retrospective study design is a limitation.  The disadvantages include information bias and 
difficulty in establishing the temporal relationship between certain variables.  The researcher relies 
on others for accurate record keeping and cannot control the exposure or outcome.  If records are 
incomplete or missing it affects the dataset.  Another possible limitation is that resource shortages 
and understaffing have made regular screening difficult so many VLBW infants may not be 
screened.  Lastly, only the worst grade of IVH is recorded on the data sheet thus we will be unable to 
comment on risk factors associated with progression from a lower grade to a higher grade.  The day 
the ultrasound is done is also not noted so temporality of the insult and IVH cannot be determined. 
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DATASHEET 
 
STUDY NUMBER  
Gestational age  
Gender  
Place of birth  
Head circumference at birth (cm)  
Maternal Data  
Antenatal care YES  NO UNKNOWN 
Antenatal steroids YES  NO UNKNOWN 
Antenatal Magnesium sulphate YES  NO UNKNOWN 
Chorioamnionitis YES  NO UNKNOWN 
Maternal HIV YES  NO UNKNOWN 
Attempted Termination of 
pregnancy YES  NO UNKNOWN 
Mode of delivery YES  NO UNKNOWN 
Multiple gestation YES  NO UNKNOWN 
Apgar score at 5 minutes  
Initial resuscitation  
Oxygen YES  NO UNKNOWN 
Face mask ventilation YES  NO UNKNOWN 
Endotracheal Tube Ventilation YES  NO UNKNOWN 
Epinephrine YES  NO UNKNOWN 
Chest compressions YES  NO UNKNOWN 
 
Temperature in degrees Celsius  
 24 
Bacterial sepsis on or before day 3 YES  NO UNKNOWN 
Gram stain POSITIVE NEGATIVE 
Oxygen on day 28 YES  NO UNKNOWN 
Cranial sonar/CT/MRI YES  NO UNKNOWN 
Worst grade of IVH Normal I II III IV 
cPVL YES  NO UNKNOWN 
Metabolic acidosis (BE-16mmol/L) YES  NO UNKNOWN 
Respiratory diagnosis  
Hyaline membrane disease YES  NO 
Congenital pneumonia  YES NO 
Atelectasis YES  NO 
Pulmonary haemorrhage YES  NO 
None YES  NO 
Respiratory support after initial 
resuscitation YES  NO YES  
CPAP duration  
IPPV duration  
Surfactant therapy YES  NO UNKNOWN 
Pneumothorax YES  NO UNKNOWN 
Patent ductus arteriosus YES  NO UNKNOWN 
Necrotising enterocolitis YES  NO UNKNOWN 
Blood transfusion YES  NO UNKNOWN 
 
 
 
 
 
 25 
Neonatal jaundice requiring phototherapy YES  NO UNKNOWN 
Neonatal jaundice requiring exchange 
transfusion YES  NO UNKNOWN 
Sepsis after day 3 YES  NO UNKNOWN 
Gram stain POSITIVE NEGATIVE 
Indomethacin usage YES  NO UNKNOWN 
Brufen usage YES  NO UNKNOWN 
Major birth defects YES  NO UNKNOWN 
HIV PCR if exposed YES  NO UNKNOWN 
Outcome DEATH DISCHARGE 
Discharge head circumference (cm) 
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Professor Gail Scher MBBCh (Wits), FCPaed (SA), MMed (Paeds) (Wits) Paediatric Neurologist Charlotte
Maxeke Johannesburg Academic Hospital Prevalence of and Risk Factors for
12Cranial Ultrasound abnormalities in Very Low Birth Weight Infants
at Charlotte Maxeke Hospital, Johannesburg A Ghoor, MB ChB; G Scher,
4MBBCh, FCPaed (SA), MMed (Paeds); D E Ballot, MBBCh, FCPaed (SA), PhD
Department of Paediatrics and Child Health, University of the Witwatersrand
and Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg,
South Africa Corresponding author:
A Ghoor (azra.ghoor@gmail.com) ABSTRACT. Background. Intraventricular haemorrhage (IVH) and cystic
periventricular leukomalacia (cPVL) contribute to neonatal mortality and morbidity. Low birth weight and
gestational age are amongst the risk factors for IVH and cPVL. Objectives. To assess how many
9very low birth weight (VLBW) infants
had cranial ultrasound screening at Charlotte Maxeke Johannesburg Academic Hospital (CMJAH) and to
determine the prevalence of cranial ultrasound abnormalities. In addition we wanted to compare the
characteristics and risk factors of those VLBW infants with cranial ultrasound abnormalities to those with
normal cranial ultrasound findings.
5Methods. This was a retrospective case-control study of
infants < 1 500g
3admitted to CMJAH between 1 January 2013 to 31
December 2015. Cases were identified as infants with IVH or cPVL. Controls were matched 1:2 based on
birth weight and gender. Results. Only 55% (856/1562) of VLBW infants had undergone cranial ultrasound
screening. The prevalence of IVH was 26% (219/856). A total of 197 cases were identified and matched with
394 controls. Antenatal care was lower in cases (71% vs 79%; P=0.039). Sepsis, ventilation, metabolic
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acidosis and patent ductus arteriosus were all significantly higher in cases. The use of antenatal steroids
was significantly higher in the grade I-II IVH/no IVH group vs grade III-IV IVH group (44% vs 25%; P=0.017).
Conclusion. The prevalence of IVH is consistent with that of developed countries. Improving antenatal care,
infection control and adequate early resuscitation could decrease the incidence of IVH and cPVL. All VLBW
infants should undergo cranial ultrasound screening. Background Periventricular-intraventricular
haemorrhage (IVH) and white matter injury (WMI), particularly cystic periventricular leukomalacia (cPVL),
are major contributors to mortality
6and long-term morbidity in preterm infants.[ 1 ,2] The
immature blood-brain barrier combined with fluctuation in cerebral blood flow, or platelet and coagulation
disorders, form the basis for IVH pathogenesis. Risk factors for IVH include low birth weight, gestational age,
prematurity, lack of antenatal steroids, asphyxia, prolonged labour, respiratory distress syndrome, recurrent
tracheal suctioning, hypoxia, hypercarbia, acidosis, patent ductus arteriosus (PDA), rapid infusion of sodium
bicarbonate and inter hospital transfer.[3] Preterm infants with cystic PVL without IVH appear to have a
different risk pattern, although the pathogenesis does involve both hypoxic-ischaemic and haemorrhagic
processes. It also appears that intrauterine inflammation and cytokine release result in oxidative stress to
white matter.[4,5] IVH can be graded according to severity from grade I-IV, with the most commonly used
classification being that of Papile et al.[6] The incidence of IVH in developed countries is about 20- 25% of
all
1very low birth weight (VLBW) infants. More than 50% of
those with severe IVH develop intellectual disability or cerebral palsy.[7] Research done in Southern Africa,
however, showed a higher incidence of between 20-50% of IVH in VLBW infants although the prevalence of
severe IVH is similar to that of developed countries.[8-10] Most neonatal units have a screening protocol in
place to detect IVH or cPVL. The American Academy of Neurology suggests cranial ultrasound screening be
performed at two time points for all
6infants with a gestational age less than 30 weeks:
between week 1 and 2 of life and at 36 to 40 weeks post menstrual age.[7] More recent studies have
evidence that
9Magnetic Resonance Imaging (MRI) done at term equivalent age
could be helpful at identifying white matter abnormalities that could cause neurocognitive delay as a long-
term outcome.[11] Cranial ultrasound, however, is still the first tool for assessing neurological injury in
preterm infants as it allows for beside investigation and sequential evaluation of evolving lesions. As
neonatal and obstetric care improves we see an increase in the survival of preterm infants and with this we
begin to see a newer burden of disease in the form of neurodevelopmental impairment.[2,12] In order to
improve the screening and management of IVH at Charlotte Maxeke Johannesburg Academic Hospital
(CMJAH) we first need to investigate the prevalence of IVH and cPVL and identify the specific risk factors
important in our population. We already know that
8low birth weight and gestational age are risk factors for IVH and therefore we
chose to conduct a study
that controlled for these possible confounders.[13] Our aim was to assess how many VLBW infants had
cranial ultrasound screening and determine the prevalence of cranial ultrasound abnormalities in our VLBW
population. We also wanted to compare the characteristics, risk factors and short-term outcomes of those
VLBW infants with cranial ultrasound abnormalities with VLBW infants with normal cranial ultrasound.
Methods The study design was a retrospective case-control study using data from the CMJAH neonatal
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database. The study population included all VLBW infants admitted to the neonatal unit, including the
intensive care unit, from 1 January 2013 to 31 December 2015. CMJAH is a tertiary hospital located in
Johannesburg, South Africa. It acts
10as a referral centre for surrounding clinics and district hospitals. The
study population included both inborn and outborn infants. Infants born with a birth weight less than or equal
to 1 500g qualify as
9very low birth weight. All VLBW infants who had the
following ultrasound abnormalities were identified as cases: IVH, post-haemorrhagic hydrocephalous or
cPVL. Cases were matched with control infants based on birth weight category and gender on a 1:2 basis.
The two most suitable controls born closest to the study patient were selected. The grading of
3IVH was done according to the classification described by Papile et al.[
6] Grade I includes bleeds
11restricted to the germinal matrix, grade II bleeds extend into the
ventricles filling less
11than 50% of the ventricle, grade III bleeding causes ventricular dilatation, and
grade IV
includes parenchymal haemorrhage. Grade III and IV bleeds constitute severe IVH. There were four birth
weight categories: less than or equal to 750g; 751 – 1 000g; 1 001 -1 250g and 1 251 – 1 500g. Infants with
major congenital abnormalities of any organ system were excluded. Infants with cranial ultrasound revealing
abnormalities such as absent corpus callosum, schizencephaly or findings with questionable significance
such as periventricular echodensities were also excluded. Data collection Data was collected from the
neonatal database REDCap (Research Electronic Data Capture) at CMJAH.[14] It is a secure web-based
application that is linked to the Vermont Oxford Network (VON) (www.vtoxford.org). The VON includes about
1 000 centres around the world that submit data about high-risk newborn infants. It is a non-profit voluntary
collaboration of health professionals aiming to improve neonatal care. Its members include both public and
private units from North America, Brazil, Canada, Europe, the Middle East, Asia and Southern Africa, to
name a few. Sixty-four units in South Africa are members of the VON. The following maternal variables were
extracted from the database for each infant: antenatal care, antenatal steroids, magnesium sulphate,
chorioamnionitis, HIV, attempted termination of pregnancy, hypertension, diabetes and mode of delivery.
Newborn variables were: place of birth, gestational age, birth weight, head circumference, gender, multiple
gestation, Apgar at 5 minutes, birth resuscitation, temperature on admission and metabolic acidosis. Birth
resuscitation included oxygen, bag mask ventilation, intubation, cardiopulmonary resuscitation and/or
intravenous adrenaline. Ultrasound findings were also recorded, particularly grade of IVH or presence of
cPVL. The neonatal course was documented including respiratory diagnosis, respiratory support, days on
continuous positive airways pressure (CPAP), days mechanically ventilated, surfactant therapy,
supplementary oxygen on day 28, indomethacin or ibuprofen exposure and bacterial sepsis (early or late).
Early sepsis constituted a
13positive blood culture within 72 hours from birth and late sepsis was a
positive blood culture > 72 hours after birth.
Other neonatal diagnoses noted were pneumothorax, patent ductus arteriosus (PDA), necrotizing
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enterocolitis (NEC), neonatal jaundice, blood transfusion, HIV testing and major birth defects. Short term
outcome namely survival to discharge was recorded. Well infants transferred to other hospitals were
considered survivors. Statistical methods
2Statistical analysis was done using SPSS Statistics (IBM) version 23. Data was
described using standard statistical methods. Continuous data with a normal
distribution was described using mean and standard deviation, while skewed
data was described using median and range. Categorical variables were
described using frequencies and percentages.
1Univariate analysis was performed to describe differences between the case
and control groups using the Pearson
5chi-squared or Fisher’s exact test for categorical variables.
Sub-analysis also included comparison between those with mild/no IVH to severe IVH and cPVL
respectively. Continuous variables were compared using independent t-tests or non-parametric tests (Mann
Whitney) as appropriate, depending on data distribution.
5A p-value ≤ 0.05 was considered significant. Basic demographic data of the
group who had not undergone cranial ultrasound was compared to the final study sample that had
undergone ultrasound to see if the sample selected was random. The variables on univariate analysis with a
p- value < 0.1 were analysed further in a stepwise logistic regression model to determine risk factors for IVH
and cPVL. Ethics
3The Human Research Ethics Committee at the University of the
Witwatersrand, Johannesburg, approved the study (Clearance certificate No.
M151195). Results There were 1562 VLBW infants
born before or on 31 December 2015 at CMJAH (accessed 01 February 2016). Cranial ultrasounds were
performed on 856 (55%) infants. The prevalence of cranial ultrasound abnormalities at CMJAH with a
comparison to the VON is shown in table 1. Of the 856 patients with cranial ultrasounds, 13 were excluded
from the study due to major birth defects. The remaining infants who underwent cranial ultrasound were then
divided into normal (580) and abnormal (263) cranial ultrasound groups. Forty infants in the “abnormal”
group (40/263, 15%) were excluded due to sonar findings that did not meet inclusion criteria. A further 26
infants with abnormal cranial ultrasound had no matching control with the correct weight category or gender
and were thus excluded. There were 186 (186/580, 32%) in the “normal” group who could not be matched
with an “abnormal” infant. There were thus 197 cases and 394 controls selected from the infants who had
undergone cranial ultrasound (see Figure 1). Table 1. Prevalence of ultrasound abnormalities in VLBW
infants at CMJAH n (%) Cranial ultrasounds done Normal cranial ultrasound
6Grade I Grade II Grade III Grade IV
Cystic PVL CMJAH 856 (54,8%) 593 (69,3%) 66 (7,7%) 92 (10,7%) 34 (4%) 27 (3,2%) 8 (1%) VON 91,1%
74,7% 10,5% 5,8% 3,5% 4,6% 2,8% Basic demographic data showed that the 47% (729/1556) of infants
admitted were males, median birth weight was 1150g and mean gestational age was 29 weeks. The
mortality of the overall group was 27% (415/1562). There were less males in the group who had not
undergone ultrasound (417/702; 45%) compared to the case/control group (303/591; 51%; P=0.029). The
median weight was higher in the group with no ultrasound (1180g vs 1090g in the case/control group;
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P=0.05). The mean gestational age of 29 weeks was the same for both groups. Mortality in the group who
had not undergone ultrasound was higher (279/706; 39% vs 99/591; 17%). This result had a significant p-
value of 0.026. This higher mortality could be accounted for by the large amount of infants who were ≤750g
in the group who had not undergone ultrasound (92/706; 13% vs 18/591; 3%). When comparing cases and
controls we found that the gender distribution was the same with males constituting 49% for both groups.
The mean birth weight for cases was 1097g and 1065g for controls. The mean gestational age was 29
weeks for both groups. The above parameters had no statistical significance, which confirms that cases and
controls were matched. The univariate comparison between case and control groups is shown in Table 2. A
higher proportion of cases were outborn. Sepsis, metabolic acidosis, ventilation and PDA were all
significantly higher in cases. Antenatal care and Apgar at 5 minutes were lower in cases. However, there
was no significant difference between the two groups when it came to antenatal steroids. The logistic
regression analysis included location of birth, antenatal care, maternal hypertension, maternal HIV, mode of
delivery, Apgar at 5 minutes, initial resuscitation with oxygen, early and late bacterial sepsis, PDA and
ventilation.
1The results are shown in table 3. The analysis showed that antenatal care
(odds ratio [OR]: 0.59; 95% confidence interval [CI]:
0.37–0.95) and Apgar greater than 7 at 5 minutes (OR: 0.53; 95% CI: 0.34–0.84) were associated with a
lower risk of abnormal cranial ultrasound. Ventilation carried a higher risk of cranial ultrasound abnormality
(OR: 2.44; 95% CI: 1.62–3.69) and early bacterial sepsis followed this trend (OR: 3.32; 95% CI: 1.3–8.34).
The rest of the variables we looked at were not significantly different between the groups. Table 2.
10Overall characteristics of cases and controls Characteristic Controls (N=
394) Outborn, n
(%) 60/392 (15) Mortality, n (%) 53/393 (14) Maternal factors Antenatal care, n (%) 307/390 (79) Antenatal
steroids, n (%) 174/386 (45) Maternal HIV, n (%) 111/392 (28) Hypertension, n (%) 105/386 (27) Mode of
delivery, n (%) Vaginal 139/385 (36) Caesarean 246/385 (64) Neonatal Factors Apgar at 5 min n (%) Less
than 7 65/360 (18) 7 or greater 295/360 (82) Resuscitation at birth with oxygen, n (%) 324/394 (82) Cases
(N=197) 45/196 (23) 46/197 (23) 137/194 (71) 73/191 (38) 72/197 (37) 37/197 (19) 83/185 (45) 102/185 (55)
52/173 (30) 121/173 (70) 148/197 (75) Early bacterial sepsis, n (%) 10/392 (3) 13/197 (7) Late bacterial
sepsis, n (%) 156/394 (40) 99/197 (50) Metabolic acidosis, n (%) 18/394 (5) 22/197 (11) Mechanical
ventilation, n (%) 102/380 (27) 95/197 (48) PDA, n (%) 57/393 (15) 45/192 (23) Maximum Bilirubin level,
mean (± SD) 167 (± 44) 179 (± 55) P-value 0.03 0.004 0.039 0.14 0.059 0.041 0.054 0.002 0.037 0.023 0.02
0.005 <0.001 0.015 0.036 *Valid cases reported for each variable (i.e. missing information was excluded)
Table 3. Parameters influencing the development of IVH, Severe IVH and cystic PVL,
1identified by logistic regression analysis Parameter OR 95% CI
P-value All cases Antenatal care 0.59 0.37 - 0.95 0.03 Apgar ≥ 7 at 5 minutes 0.53 0.34 - 0.84 0.006 Early
bacterial sepsis 3.32 1.32 - 8.34 0.011 Mechanical ventilation 2.44 1.62 - 3.69 <0.001 Severe IVH Outborn
3.0 1.22 - 7.41 0.017 Apgar ≥ 7 at 5 minutes 0.21 0.10 - 0.43 <0.001 Mechanical ventilation 3.64 1.73 - 7.62
0.001 Cystic PVL Sex (male) 0.11 0.01 - 1.22 0.072 Chorioamnionitis 45.73 6.27 - 333.68 <0.001
Mechanical ventilation 15.92 1.54 - 164.36 0.02 *Valid cases reported for each variable (i.e. missing
information was excluded) Sub-analyses We also looked further at severe IVH within the selected cases,
compared with mild/no IVH from within the control group. Significant results are in Table 4. The use of
antenatal steroids in the mild/no IVH group appears to be higher (232/527; 44% vs 11/44; 25%: P=0.017).
Logistic regression analysis revealed that both outborn and ventilated VLBW infants had a higher
7risk of severe IVH. An Apgar score of
7 or greater had indicated
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7a lower risk of severe IVH.
The results are shown in Table 3. The sample of infants with cystic PVL was compared to those with mild/no
IVH and results are detailed in table 5. The significant factors associated with cystic PVL on univariate
analysis were sex (female), chorioamnionitis, blood transfusion, late bacterial sepsis as well as ventilation.
Multivariate analysis (table 3) revealed that chorioamnionitis (OR: 45.73; 95% CI: 6.27–333.68) and
ventilation (OR: 15.92; 95% CI: 1.54–164.36) hold a high risk of cystic PVL. Table 4. Severe IVH compared
to mild IVH/no IVH Mild IVH/No Characteristic abnormality (N=536) Outborn, n (%) 81/534 (15) Mortality, n
(%) 78/535 (15) Maternal factors Antenatal care, n (%) 410/531 (77) Antenatal steroids, n (%) 232/527 (44)
Neonatal factors Apgar at 5 min, n (%) Less than 7 7 or greater Early bacterial sepsis, n (%) Oxygen on day
28, n (%) Metabolic acidosis, n (%) Mechanical ventilation, n (%) Severe IVH P-value (N=47) 17/47 (36)
17/47 (36) 0.001 <0.001 28/46 (61) 0.019 11/44 (25) 0.017 <0.001 91/485 (19) 24/41 (59) 394/485 (81)
17/41 (41) 18/535 (3) 5/47 (11) 0.031 205/517 (40) 23/41 (56) 0.047 31/536 (6) 7/47 (15) 0.026 161/519 (31)
29/46 (63) <0.001 *Valid cases reported for each variable (i.e. missing information was excluded) Table 5.
Cystic PVL compared to mild IVH/no IVH Characteristic Sex (male), n (%) Mortality, n (%) Chorioamnionitis,
n (%) Blood transfusion, n (%) Late bacterial sepsis, n (%) Mechanical ventilation, n (%) Mild IVH/No
abnormality (N=536) 275/536 (51) 78/535 (15) 18/525 (3) 308/532 (58) 224/536 (42) 161/518 (31) Severe
IVH (N=8) 1/8 (13) 4/8 (50) 3/6 (50) 8/8 (100) 7/8 (88) 7/8 (88) P-value 0.035 0.001 0.001 0.024 0.012 0.002
*Valid cases reported for each variable (i.e. missing information was excluded)
8Discussion The main objectives of this study were to look at the
prevalence of cranial ultrasound abnormalities and associated risk factors. According to the screening
protocol at CMJAH every VLBW should have an ultrasound within the first 7 days of life, at 10-14 days of life
and one before discharge.[15] Only 55% of VLBW infants admitted in the study period had cranial
ultrasounds, as compared to the VON where more than 90% of VLBW infants had cranial sonars. Reasons
for the low coverage rate in our unit include staff shortages at times but more importantly the lack of
appropriate equipment to perform ultrasound. The unit only has one sonar machine that is often not
functional. It was shown that patients who did not undergo cranial ultrasound appeared to have a higher
mortality rate than those who had undergone an ultrasound. This is partly explained by the fact that 99/706
(13%) of infants in that group were ≤ 750g. These infants already make up a high-risk group related to the
extreme prematurity and are likely to have demised before an ultrasound could be performed. Well VLBW
infants admitted with higher birth weights are often sent to the kangaroo mother care (KMC) ward and
discharged quickly without undergoing cranial ultrasound screening. The prevalence of IVH (26%) appears
to be consistent with that of studies done in developed countries and is similar to that reported in the VON
over the same time period.[7] With improvement of perinatal care the prevalence appears to have decreased
compared to a study done at our sister unit Baragwanath Hospital in Soweto 20 years ago, which showed a
prevalence of 52% in VLBW infants.[8] The prevalence of severe IVH in this study (7%) is also less than
reported in the VON and studies from both developed and developing countries.[7-9] This study confirms
what is already known, that infants with IVH have higher mortality and that lack of antenatal care, birth
asphyxia and sepsis appear to be associated with development of IVH. Mechanical ventilation and PDA also
had an increased association with IVH and this can be explained by fluctuations in cerebral blood flow.[3]
Inborn patients tended to have less IVH than those outborn and there are many factors that could explain
the higher risk including delay in transfer, inadequate monitoring or lack of appropriate management at
referral centres. Contrary to other studies, which show a decrease in IVH with antenatal steroids, our study
did not show a significant difference between the use of antenatal steroids in the case and control groups.[3]
This may be due to the fact that the administration of antenatal steroids in our setting is lower than other
settings. Only 28% (431/1562) of mothers of VLBW infants had received steroids as compared to 83.5%
coverage in the VON during the same period. The reason is possibly due to late presentation of unbooked
mothers.[16] However, the sub-analysis of the group with severe IVH did show an association with antenatal
steroids. Maternal hypertension also appeared to be
7associated with a lower incidence of overall IVH and this is consistent with
other studies.[13] In terms of the multivariate logistic regression analysis for all IVH cases, the major
protective factors were antenatal care and Apgar ≥ 7 at 5 minutes (adequate resuscitation). Sepsis and
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mechanical ventilation showed about a 3-fold increase in IVH and both of those factors can be modified by
preventative measures. Severe IVH had similar association on multivariate analysis to overall IVH, but
infants that were outborn were shown to have a 3-fold risk of severe IVH and this could be prevented by
transport of mothers in premature labour to centres with appropriate neonatal services before delivery. In
this study the prevalence of cystic PVL was only 1% although mortality was highest in this group which is
consistent with previous studies.[2] As explained earlier MRI is a better tool to assess WMI, but in our setting
this is not feasible due to lack of adequate MRI facilities to service the neonatal unit. Studies seeking to
describe a difference between cystic PVL and IVH have shown that the two are not mutually exclusive and
there is a possible causal relationship between the two even though cystic PVL can be seen as a single
pathology in some cases.[4,5] In this study the sub-analysis showed that the female gender,
chorioamnionitis and blood transfusion had significant association with cystic PVL as well as sepsis and
mechanical ventilation, which were both risk factors for IVH as well. However, on multivariate logistic
regression analysis the gender association was shown to have an insignificant 95% CI and only
chorioamnionitis and mechanical ventilation appeared significant, although confidence intervals were wide
owing to the small sample. Limitations The retrospective study design was a limitation. The disadvantages
include information bias and difficulty in establishing the temporal relationship between certain variables.
Records that were incomplete or missing affect the dataset. Another limitation is the lack of resources,
including both staff and equipment, which resulted in deviation from the ultrasound screening protocol and
resulted in 45% of VLBW infants not being screened. WMI may be largely underestimated by cranial
ultrasound alone. In our setting the access to MRI is inadequate. Conclusion This retrospective matched
case-control study showed that the prevalence of IVH is consistent with that of developed countries and it is
encouraging to note that severe IVH is lower in our unit. It confirmed the risk factors for IVH and cystic PVL
at CMJAH are in keeping with that found globally. The increased mortality and morbidity in infants with IVH
would suggest that we try to modify the risk factors found to be significant in our population. Access and
awareness of early antenatal care is an important factor in preventing poor perinatal outcome. Neonatal
resuscitation training in clinics and hospitals should be given priority as well as correct protocols for transfer
of infants as well as possible early transfer of mothers in preterm labour to appropriate centres. Infection
control and methods to decrease the need for mechanical ventilation are important interventions that could
decrease the incidence of IVH. In terms of ultrasound screening early detection of lesions gives infants a
chance of early intervention services. Therefore efforts should be made to ensure that all VLBW infants
undergo ultrasound screening. Furthermore, early identification of patients with poor prognostic factors could
assist with decision-making regarding the maximum level of care offered and allocation of resources in an
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